Logo image of GROV

GROVE COLLABORATIVE HOLDINGS (GROV) Stock Fundamental Analysis

NYSE:GROV - US39957D2018 - Common Stock

1.52 USD
-0.04 (-2.56%)
Last: 8/29/2025, 8:27:32 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to GROV. GROV was compared to 122 industry peers in the Specialty Retail industry. GROV may be in some trouble as it scores bad on both profitability and health. GROV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GROV has reported negative net income.
In the past year GROV has reported a negative cash flow from operations.
In the past 5 years GROV always reported negative net income.
In the past 5 years GROV always reported negative operating cash flow.
GROV Yearly Net Income VS EBIT VS OCF VS FCFGROV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

GROV has a worse Return On Assets (-47.88%) than 91.87% of its industry peers.
Looking at the Return On Equity, with a value of -218.33%, GROV is doing worse than 77.24% of the companies in the same industry.
Industry RankSector Rank
ROA -47.88%
ROE -218.33%
ROIC N/A
ROA(3y)-41.12%
ROA(5y)-44.93%
ROE(3y)-250.11%
ROE(5y)-245.83%
ROIC(3y)N/A
ROIC(5y)N/A
GROV Yearly ROA, ROE, ROICGROV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

GROV's Gross Margin of 53.08% is amongst the best of the industry. GROV outperforms 83.74% of its industry peers.
In the last couple of years the Gross Margin of GROV has grown nicely.
GROV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.05%
GM growth 5Y8.48%
GROV Yearly Profit, Operating, Gross MarginsGROV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

2

2. Health

2.1 Basic Checks

GROV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GROV has more shares outstanding
The debt/assets ratio for GROV has been reduced compared to a year ago.
GROV Yearly Shares OutstandingGROV Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
GROV Yearly Total Debt VS Total AssetsGROV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -12.26, we must say that GROV is in the distress zone and has some risk of bankruptcy.
GROV has a worse Altman-Z score (-12.26) than 93.50% of its industry peers.
GROV has a Debt/Equity ratio of 0.57. This is a neutral value indicating GROV is somewhat dependend on debt financing.
GROV's Debt to Equity ratio of 0.57 is in line compared to the rest of the industry. GROV outperforms 48.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z -12.26
ROIC/WACCN/A
WACC14.7%
GROV Yearly LT Debt VS Equity VS FCFGROV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

2.3 Liquidity

A Current Ratio of 1.48 indicates that GROV should not have too much problems paying its short term obligations.
The Current ratio of GROV (1.48) is better than 60.98% of its industry peers.
A Quick Ratio of 0.62 indicates that GROV may have some problems paying its short term obligations.
GROV has a better Quick ratio (0.62) than 60.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 0.62
GROV Yearly Current Assets VS Current LiabilitesGROV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

2

3. Growth

3.1 Past

GROV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.13%, which is quite impressive.
Looking at the last year, GROV shows a very negative growth in Revenue. The Revenue has decreased by -21.54% in the last year.
Measured over the past years, GROV shows a decrease in Revenue. The Revenue has been decreasing by -2.69% on average per year.
EPS 1Y (TTM)53.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.29%
Revenue 1Y (TTM)-21.54%
Revenue growth 3Y-19.06%
Revenue growth 5Y-2.69%
Sales Q2Q%-15.5%

3.2 Future

The Earnings Per Share is expected to grow by 21.73% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -0.15% on average over the next years.
EPS Next Y19.05%
EPS Next 2Y21.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-10.26%
Revenue Next 2Y-0.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GROV Yearly Revenue VS EstimatesGROV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
GROV Yearly EPS VS EstimatesGROV Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -1 -2 -3 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GROV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GROV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GROV Price Earnings VS Forward Price EarningsGROV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GROV Per share dataGROV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

A more expensive valuation may be justified as GROV's earnings are expected to grow with 21.73% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.73%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GROV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GROVE COLLABORATIVE HOLDINGS

NYSE:GROV (8/29/2025, 8:27:32 PM)

1.52

-0.04 (-2.56%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-10 2025-11-10
Inst Owners26.09%
Inst Owner Change3.03%
Ins Owners10.06%
Ins Owner Change2.52%
Market Cap62.34M
Analysts82.86
Price Target1.53 (0.66%)
Short Float %6.46%
Short Ratio6.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-90.72%
Min EPS beat(2)-145.1%
Max EPS beat(2)-36.35%
EPS beat(4)1
Avg EPS beat(4)-47.74%
Min EPS beat(4)-145.1%
Max EPS beat(4)73.5%
EPS beat(8)2
Avg EPS beat(8)-33.89%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.85%
Min Revenue beat(2)-9.16%
Max Revenue beat(2)-0.53%
Revenue beat(4)0
Avg Revenue beat(4)-5.06%
Min Revenue beat(4)-9.16%
Max Revenue beat(4)-0.53%
Revenue beat(8)1
Avg Revenue beat(8)-4.06%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-50%
PT rev (3m)-40%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.4%
Revenue NY rev (1m)-1.12%
Revenue NY rev (3m)-5.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 4.75
P/tB 5.95
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS4.72
BVpS0.32
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.88%
ROE -218.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.08%
FCFM N/A
ROA(3y)-41.12%
ROA(5y)-44.93%
ROE(3y)-250.11%
ROE(5y)-245.83%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.05%
GM growth 5Y8.48%
F-Score3
Asset Turnover3.23
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.26%
Cap/Sales 0.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 0.62
Altman-Z -12.26
F-Score3
WACC14.7%
ROIC/WACCN/A
Cap/Depr(3y)47.64%
Cap/Depr(5y)75.11%
Cap/Sales(3y)1.11%
Cap/Sales(5y)1.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.29%
EPS Next Y19.05%
EPS Next 2Y21.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.54%
Revenue growth 3Y-19.06%
Revenue growth 5Y-2.69%
Sales Q2Q%-15.5%
Revenue Next Year-10.26%
Revenue Next 2Y-0.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year105.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y92.2%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y94.23%
OCF growth 3YN/A
OCF growth 5YN/A